| XENLETA Nabriva Therapeutics US, Inc.
1985919 09 Sep 2019 | on 27 Nov 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for treating respiratory diseases; antibiotics; pharmaceutical preparations for the treatment of pneumonia and bacterial infections, namely, community-acquired bacterial pneumonia (CABP). | | | XENLETA & Design Nabriva Therapeutics US, Inc.
1984763 12 Sep 2019 | on 27 Nov 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for treating respiratory illnesses; antibiotics; anti-infectives; pharmaceutical preparations for the treatment of pneumonia and bacterial infections, namely, community-acquired bacterial pneumonia (CABP) | | 
